Balchem (BCPC) Q2 EPS Jumps 16.5%
(NASDAQ:BCPC), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue and non-GAAP profits, well surpassing analyst expectations for Q2 FY2025. Non-GAAP earnings per share stood at $1.27, compared to a projected $1.12. Revenue (GAAP) climbed to $255.5 million, beating projections of $250.3 million. Each core business segment posted growth, with notable efficiency gains and a significant capital investment announcement. The quarter underscored continued momentum after a robust start to the year.
Source: Analyst estimates for the quarter provided by FactSet.
Balchem develops and manufactures a broad mix of nutritional ingredients, functional food components, and specialty performance chemicals. The business is organized into three main segments: Human Nutrition Health (ingredients and supplements for people), Animal Nutrition Health (feed ingredients for livestock), and Specialty Products (such as performance gases and plant nutrients).
Source Fool.com
Balchem Corp. B Aktie
Leichte Kaufstimmung für Balchem Corp. B: Mehr Buy- als Sell-Einschätzungen.
Ein prognostiziertes Kursziel von 160 € für Balchem Corp. B zeigt ein Potenzial von über 20% im Vergleich zum aktuellen Kurs von 132.0 €.
